CLN.WA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 17:00):

Stats
Dagens volum	49 759.00
Gjennomsnittsvolum	19 089.00
Markedsverdi	792.40M
EPS	PLN-0.130 ( 2023-11-22 )
Neste inntjeningsdato	( PLN0 ) 2024-05-22
Last Dividend	PLN0.0900 ( 2023-06-29 )
Next Dividend	PLN0 ( N/A )
P/E	-28.22
ATR14	PLN0.0350 (0.23%)

Volum Korrelasjon

Lang: 0.07 (neutral)

Kort: -0.65 (moderate negative)

Signal:(45.475) Neutral

Celon Pharma S.A. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Celon Pharma S.A. Korrelasjon - Valuta/Råvare

-0.61
( weak negative )

-0.78
( moderate negative )

0.00
( neutral )

-0.58
( weak negative )

0.47
( neutral )

0.71
( moderate )

Celon Pharma S.A. Økonomi

Annual	2023
Omsetning:	PLN164.39M
Bruttogevinst:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2023
Omsetning:	PLN164.39M
Bruttogevinst:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2022
Omsetning:	PLN161.92M
Bruttogevinst:	PLN95.45M (58.95 %)
EPS:	PLN-0.770

FY	2021
Omsetning:	PLN169.56M
Bruttogevinst:	PLN107.84M (63.60 %)
EPS:	PLN-0.111

Financial Reports:

No articles found.

Celon Pharma S.A. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0.0900 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)

Celon Pharma S.A. Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.652 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	PLN0.170	2017-05-31
Last Dividend	PLN0.0900	2023-06-29
Next Dividend	PLN0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	7	--
Total Paid Out	PLN1.110	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	1.652
Div.Growth Potential Score	0
Div. Directional Score	0.537	--

Next Divdend (Est)
(2025-04-08)

PLN0.0386 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for WSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
ASB.WA	Ex Dividend Knight	2023-06-23	Semi-Annually	0.00%
MBR.WA	Ex Dividend Junior	2023-06-30	Annually	0.00%
1AT.WA	Ex Dividend Junior	2023-06-21	Sporadic	0.00%
K2H.WA	Ex Dividend Junior	2023-07-03	Sporadic	0.00%
ERB.WA	Ex Dividend Junior	2023-05-25	Sporadic	0.00%
ULG.WA	Ex Dividend Junior	2023-06-16	Annually	0.00%
CIE.WA	Ex Dividend Junior	2023-06-26	Sporadic	0.00%
PZU.WA	Ex Dividend Junior	2023-09-06	Annually	0.00%
BCS.WA	Ex Dividend Knight	2023-07-06	Annually	0.00%
NTT.WA	Ex Dividend Junior	2023-09-26	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.135	1.500	-2.69	-4.04	[0 - 0.5]
returnOnAssetsTTM	-0.0388	1.200	-1.295	-1.554	[0 - 0.3]
returnOnEquityTTM	-0.0481	1.500	-1.645	-2.47	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.20	0.800	4.01	3.21	[1 - 3]
quickRatioTTM	1.893	0.800	3.57	2.86	[0.8 - 2.5]
cashRatioTTM	0.375	1.500	9.03	10.00	[0.2 - 2]
debtRatioTTM	0.0449	-1.500	9.25	-10.00	[0 - 0.6]
interestCoverageTTM	-8.21	1.000	-4.15	-4.15	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.801	2.00	-0.400	-0.801	[0 - 20]
debtEquityRatioTTM	0.0574	-1.500	9.77	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.606	1.000	3.24	3.24	[0.2 - 0.8]
operatingProfitMarginTTM	-0.131	1.000	-4.62	-4.62	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.325	1.000	-2.92	-2.92	[0.2 - 2]
assetTurnoverTTM	0.289	0.800	-1.408	-1.127	[0.5 - 2]
Total Score				1.652

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-36.05	1.000	-3.74	0	[1 - 100]
returnOnEquityTTM	-0.0481	2.50	-1.058	-2.47	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.801	2.00	-0.267	-0.801	[0 - 30]
dividendYielPercentageTTM	0.580	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0506	1.000	-3.76	0	[0.1 - 0.5]
Total Score				-0.579

Celon Pharma S.A.

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.